Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation, fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.
종목 코드 STXS
회사 이름Stereotaxis Inc
상장일Aug 12, 2004
CEOMr. David Leo Fischel
직원 수139
유형Ordinary Share
회계 연도 종료Aug 12
주소710 N Tucker Blvd
도시ST. LOUIS
증권 거래소NYSE American Consolidated
국가United States of America
우편 번호63101
전화13146786100
웹사이트https://www.stereotaxis.com/
종목 코드 STXS
상장일Aug 12, 2004
CEOMr. David Leo Fischel
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음